결핵흉막염 치료 중에 발생한 역설적 반응에 대한 연구

Paradoxical Response Developed during the Antituberculous Treatment in Tuberculous Pleurisy

  • 송은주 (을지대학교 의과대학 을지병원 내과학교실) ;
  • 백대현 (을지대학교 의과대학 을지병원 내과학교실) ;
  • 정준영 (을지대학교 의과대학 을지병원 내과학교실) ;
  • 이상렬 (을지대학교 의과대학 을지병원 내과학교실) ;
  • 이명하 (을지대학교 의과대학 을지병원 내과학교실) ;
  • 이성혁 (을지대학교 의과대학 을지병원 내과학교실) ;
  • 이재형 (을지대학교 의과대학 을지병원 내과학교실) ;
  • 이기덕 (을지대학교 의과대학 을지병원 내과학교실) ;
  • 이병훈 (을지대학교 의과대학 을지병원 내과학교실) ;
  • 김상훈 (을지대학교 의과대학 을지병원 내과학교실)
  • Song, Eun Ju (Department of Internal Medicine, Eulji Hospital, College of Medicine, Eulji University) ;
  • Baek, Dae Hyun (Department of Internal Medicine, Eulji Hospital, College of Medicine, Eulji University) ;
  • Jung, Jun Young (Department of Internal Medicine, Eulji Hospital, College of Medicine, Eulji University) ;
  • Lee, Sang Ryul (Department of Internal Medicine, Eulji Hospital, College of Medicine, Eulji University) ;
  • Lee, Myong Ha (Department of Internal Medicine, Eulji Hospital, College of Medicine, Eulji University) ;
  • Lee, Sung Hyuk (Department of Internal Medicine, Eulji Hospital, College of Medicine, Eulji University) ;
  • Lee, Jae Hyung (Department of Internal Medicine, Eulji Hospital, College of Medicine, Eulji University) ;
  • Lee, Ki Deok (Department of Internal Medicine, Eulji Hospital, College of Medicine, Eulji University) ;
  • Lee, Byoung Hoon (Department of Internal Medicine, Eulji Hospital, College of Medicine, Eulji University) ;
  • Kim, Sang Hoon (Department of Internal Medicine, Eulji Hospital, College of Medicine, Eulji University)
  • 투고 : 2008.04.29
  • 심사 : 2008.06.02
  • 발행 : 2008.06.30

초록

연구배경: 결핵환자에서 항결핵제 치료 중 초기에 병변의 호전 이후 방사선학적, 임상적으로 이전의 병변이 악화 되거나 새로운 병변이 발생하는 경우를 역설적 반응이라 정의한다. 결핵흉막염에서의 역설적 반응 발생과 이와 관련된 인자에 대해서 알려진 바는 많지 않다. 방 법: 2004년 1월부터 2006년 12월까지 결핵흉막염으로 진단받고 4개월 이상 항결핵제를 복용한 환자를 대상으로 하였다. 항결핵제 투약 전과 투약 후 흉부 방사선의 변화를 연속적으로 살펴보고 치료시작 2주 후에 이전의 병변의 악화나 새로운 병변이 생긴 경우를 역설적 반응이 발생한 것으로 판정하였다. 역설적 반응군이 발생하였던 환자군과 발생하지 않았던 환자군 간의 임상적인 특성과 흉수, 혈액 검사를 비교하였다. 결 과: 대상환자 77명 중 역설적 반응을 보인 환자는 16명(21%)이었다. 역설적 반응을 보인 시기는 항결핵제 사용 후 평균 38.6일이었으며, 병변의 크기가 줄어드는데 걸리는 시간은 평균 32.1일이었다. 역설적 반응은 젊은환자에서(30.5세 vs 39.0세), 그리고 흉수의 백혈구 중 림프구의 백분율이 높았던 경우에서(82.1% vs 69.6%) 많이 발생하였다. 결 론: 결핵흉막염의 항결핵제 치료 중에 발생하는 역설적 반응은 드물지 않았으며 환자의 연령과 흉수의 백혈구 중 림프구의 백분율이 역설적 반응의 발생빈도와 관련이 있었다.

Background: A paradoxical response is defined as the radiological and clinical worsening of a previous lesion or the development of new lesion after initial improvement during theprocess of antituberculous treatment. The related factors for the development of a paradoxical response in patients with tuberculous pleurisy are not certain. Methods: We selected patients with tuberculous pleurisy who had been treated for more than 4 months. The changes onthe serial chest X-ray findings before and after treatment were reviewed. Paradoxical responses were regarded as any worsening or development of new lesion at least 2 weeks after the initiation of treatment. The baseline clinical characteristics and laboratory findings of the peripheral blood and pleural fluid were compared between the patients with a paradoxical response and the patients without a paradoxical response. Results: Paradoxical responses appeared in sixteen patients (21%) among the 77 patients.It took a mean of 38.6 days after the treatment and the time to resolve the paradoxical response was a mean of 32.1 days. For the patients with a paradoxical response, the median age was younger (30.5 years vs 39.0 years, respectively) and the lymphocytic percentage of white blood cells in the pleural fluid was higher (82.1% vs 69.6%, respectively) than for the patients without a paradoxical response. Conclusion: The development of a paradoxical response during the treatment of patients with tuberculous pleurisy was not rare and this was related with the age of the patients and the percentage of lymphocytic white blood cells in the pleural fluid.

키워드

참고문헌

  1. Hung SC, Chang SC. New pulmonary lesions during therapy for extrapulmonary tuberculosis. Chest 1999; 116:1794-7 https://doi.org/10.1378/chest.116.6.1794
  2. Onal IK, Bayraktar Y, Unal S. Paradoxical deterioration during the course of antituberculous treatment. J Natl Med Assoc 2006;98:954-5
  3. Al-Majed SA. Study of paradoxical response to chemotherapy in tuberculous pleural effusion. Respir Med 1996;90:211-4 https://doi.org/10.1016/S0954-6111(96)90289-9
  4. Marshall BG, Chambers MA. Central nervous system tuberculosis: the paradox of the host immune response. J Infect 1998;36:3-4 https://doi.org/10.1016/S0163-4453(98)92838-9
  5. DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 2000;133:447-54 https://doi.org/10.7326/0003-4819-133-6-200009190-00013
  6. Campbell IA, Dyson AJ. Lymph node tuberculosis: a comparison of various methods of treatment. Tubercle 1977;58:171-9 https://doi.org/10.1016/0041-3879(77)90041-1
  7. Kim SH, Chung HY, Lee GD, Shin MG, Jung TS, Jin BC, et al. Clinical characteristics of paradoxical response to chemotherapy in pulmonary tuberculosis. Tuberc Respir Dis 2002;53:27-35 https://doi.org/10.4046/trd.2002.53.1.27
  8. Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK, Woo PC, et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002;21:803-9 https://doi.org/10.1007/s10096-002-0821-2
  9. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998;158:157-61 https://doi.org/10.1164/ajrccm.158.1.9712001
  10. Navas E, Martin-Davila P, Moreno L, Pintado V, Casado JL, Fortun J, et al. Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Arch Intern Med 2002;162:97-9 https://doi.org/10.1001/archinte.162.1.97
  11. Wendel KA, Alwood KS, Gachuhi R, Chaisson RE, Bishai WR, Sterling TR. Paradoxical worsening of tuberculosis in HIV-infected persons. Chest 2001;120: 193-7 https://doi.org/10.1378/chest.120.1.193
  12. Valdes L, San Jose E, Alvarez D, Valle JM. Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy. Eur Respir J 1996;9:747-51 https://doi.org/10.1183/09031936.96.09040747
  13. Cheng VC, Yam WC, Woo PC, Lau SK, Hung IF, Wong SP, et al. Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis 2003; 22:597-602 https://doi.org/10.1007/s10096-003-0998-z
  14. Jafari C, Ernst M, Strassburg A, Greinert U, Kalsdorf B, Kirsten D, et al. Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot. Eur Respir J 2008;31:261-5 https://doi.org/10.1183/09031936.00096707
  15. Viard JP, Mocroft A, Chiesi A, Kirk O, Roge B, Panos G, et al. Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis 2001;183:1290-4. https://doi.org/10.1086/319678
  16. Toossi Z, Young TG, Averill LE, Hamilton BD, Shiratsuchi H, Ellner JJ. Induction of transforming growth factor beta 1 by purified protein derivative of Mycobacterium tuberculosis. Infect Immun 1995;63:224-8
  17. Hiraoka K, Nagata N, Kawajiri T, Suzuki K, Kurokawa S, Kido M, et al. Paradoxical pleural response to antituberculous chemotherapy and isoniazid-induced lupus: review and report of two cases. Respiration 1998;65:152-5 https://doi.org/10.1159/000029251
  18. Reiser M, Fatkenheuer G, Diehl V. Paradoxical expansion of intracranial tuberculomas during chemotherapy. J Infect 1997;35:88-90 https://doi.org/10.1016/S0163-4453(97)91241-X
  19. Kim JY, Kwon JH, Kim MJ, Chang HW, Hwang JS, Cho KB, et al. Paradoxical response during antituberculous treatment for abdominal tuberculosis. J Korean Radiol Soc 2006;55:599-605 https://doi.org/10.3348/jkrs.2006.55.6.599
  20. Yano S, Kobayashi K, Kato K, Tokuda Y, Ikeda T, Takeyama H. Paradoxical worsening of pulmonary Mycobacterium abscessus. Respir Med 2007;101:868-70 https://doi.org/10.1016/j.rmed.2006.06.026
  21. Jang KJ, Jwa CS, Kim KH, Kang JK. Paradoxical deterioration of intramedullary spinal tuberculomas during antituberculous therapy. J Korean Neurosurg Soc 2007; 41:408-10
  22. Subhash HS, Supriya S, Prakash B, Thomas K. Acute respiratory distress syndrome as a paradoxical response to anti-tuberculous and anti-retroviral therapy. Indian J Tuberc 2006;53:157-60